MIRUM PHARMACEUTICALS INC's ticker is MIRM and the CUSIP is 604749101. A total of 86 filers reported holding MIRUM PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.92 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,675,943 | +599.3% | 432,783 | +472.5% | 0.01% | +400.0% |
| Q2 2023 | $1,955,772 | +113475.6% | 75,600 | +5.4% | 0.00% | 0.0% |
| Q1 2023 | $1,722 | +20.6% | 71,694 | -2.1% | 0.00% | 0.0% |
| Q4 2022 | $1,428 | -99.9% | 73,248 | -12.5% | 0.00% | 0.0% |
| Q3 2022 | $1,760,000 | +132.8% | 83,745 | +115.8% | 0.00% | – |
| Q2 2022 | $756,000 | -54.8% | 38,803 | -48.6% | 0.00% | -100.0% |
| Q1 2022 | $1,672,000 | +1014.7% | 75,555 | +585.6% | 0.00% | – |
| Q4 2021 | $150,000 | -24.6% | 11,020 | 0.0% | 0.00% | – |
| Q3 2021 | $199,000 | +4.2% | 11,020 | 0.0% | 0.00% | – |
| Q2 2021 | $191,000 | -32.7% | 11,020 | -23.0% | 0.00% | – |
| Q1 2021 | $284,000 | -34.4% | 14,320 | -42.3% | 0.00% | – |
| Q4 2020 | $433,000 | -10.0% | 24,811 | -0.5% | 0.00% | – |
| Q3 2020 | $481,000 | +138.1% | 24,946 | +140.0% | 0.00% | – |
| Q2 2020 | $202,000 | – | 10,396 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 3,566,912 | $62,278,000 | 4.80% |
| RiverVest Venture Management LLC | 1,921,118 | $33,543,000 | 3.68% |
| Burrage Capital Management LLC | 161,628 | $2,822,000 | 2.15% |
| AIGH Capital Management LLC | 274,583 | $4,794,000 | 1.95% |
| NEA Management Company, LLC | 4,187,801 | $73,119,000 | 1.93% |
| Novo Holdings A/S | 2,445,147 | $42,692,000 | 1.83% |
| Sio Capital Management, LLC | 494,743 | $8,638,000 | 1.77% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,448,912 | $60,218,000 | 1.19% |
| Rock Springs Capital Management LP | 1,496,525 | $26,129,000 | 0.55% |
| Prosight Management, LP | 60,250 | $1,052,000 | 0.49% |